348 related articles for article (PubMed ID: 6719111)
1. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.
Igisu H; Suzuki K
Science; 1984 May; 224(4650):753-5. PubMed ID: 6719111
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides.
Ichioka T; Kishimoto Y; Brennan S; Santos GW; Yeager AM
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4259-63. PubMed ID: 2884662
[TBL] [Abstract][Full Text] [Related]
3. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis.
Svennerholm L; Vanier MT; Månsson JE
J Lipid Res; 1980 Jan; 21(1):53-64. PubMed ID: 7354254
[TBL] [Abstract][Full Text] [Related]
4. [Psychosine: a "toxin" produced in the brain--its mechanism of action].
Igisu H
J UOEH; 1989 Dec; 11(4):487-93. PubMed ID: 2558407
[TBL] [Abstract][Full Text] [Related]
5. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.
Kobayashi T; Shinoda H; Goto I; Yamanaka T; Suzuki Y
Biochem Biophys Res Commun; 1987 Apr; 144(1):41-6. PubMed ID: 3579916
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.
Belleri M; Ronca R; Coltrini D; Nico B; Ribatti D; Poliani PL; Giacomini A; Alessi P; Marchesini S; Santos MB; Bongarzone ER; Presta M
Brain; 2013 Sep; 136(Pt 9):2859-75. PubMed ID: 23983033
[TBL] [Abstract][Full Text] [Related]
9. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine.
Kobayashi T; Goto I; Yamanaka T; Suzuki Y; Nakano T; Suzuki K
Ann Neurol; 1988 Oct; 24(4):517-22. PubMed ID: 3239954
[TBL] [Abstract][Full Text] [Related]
10. Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
Graziano AC; Parenti R; Avola R; Cardile V
Apoptosis; 2016 Jan; 21(1):25-35. PubMed ID: 26459425
[TBL] [Abstract][Full Text] [Related]
11. Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture.
White AB; Givogri MI; Lopez-Rosas A; Cao H; van Breemen R; Thinakaran G; Bongarzone ER
J Neurosci; 2009 May; 29(19):6068-77. PubMed ID: 19439584
[TBL] [Abstract][Full Text] [Related]
12. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach.
Esch SW; Williams TD; Biswas S; Chakrabarty A; LeVine SM
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):779-87. PubMed ID: 14528915
[TBL] [Abstract][Full Text] [Related]
14. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
Suzuki K
Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
[TBL] [Abstract][Full Text] [Related]
15. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.
Li Y; Xu Y; Benitez BA; Nagree MS; Dearborn JT; Jiang X; Guzman MA; Woloszynek JC; Giaramita A; Yip BK; Elsbernd J; Babcock MC; Lo M; Fowler SC; Wozniak DF; Vogler CA; Medin JA; Crawford BE; Sands MS
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20097-20103. PubMed ID: 31527255
[TBL] [Abstract][Full Text] [Related]
16. Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry.
Whitfield PD; Sharp PC; Taylor R; Meikle P
J Lipid Res; 2001 Dec; 42(12):2092-5. PubMed ID: 11734583
[TBL] [Abstract][Full Text] [Related]
17. Developmental defects and aberrant accumulation of endogenous psychosine in oligodendrocytes in a murine model of Krabbe disease.
Inamura N; Kito M; Go S; Kishi S; Hosokawa M; Asai K; Takakura N; Takebayashi H; Matsuda J; Enokido Y
Neurobiol Dis; 2018 Dec; 120():51-62. PubMed ID: 30176352
[TBL] [Abstract][Full Text] [Related]
18. Visual System Impairment in a Mouse Model of Krabbe Disease: The Twitcher Mouse.
Tonazzini I; Cerri C; Del Grosso A; Antonini S; Allegra M; Caleo M; Cecchini M
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33374753
[TBL] [Abstract][Full Text] [Related]
19. Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease.
Won JS; Kim J; Paintlia MK; Singh I; Singh AK
Brain Res; 2013 May; 1508():44-52. PubMed ID: 23438514
[TBL] [Abstract][Full Text] [Related]
20. Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease.
Potter GB; Santos M; Davisson MT; Rowitch DH; Marks DL; Bongarzone ER; Petryniak MA
Hum Mol Genet; 2013 Sep; 22(17):3397-414. PubMed ID: 23620143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
